References
- Bolinder, G., et al., 1997. Smokeless tobacco use and atherosclerosis: an ultrasonographic investigation of carotid intima media thickness in healthy middle-aged men. Atherosclerosis, 132 (1), 95–103.
- Furchgott, R. F. and Zawadzki, J. V., 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 288 (5789), 373–376.
- Gimbrone, M.A., 1976. Culture of vascular endothelium. Progress in Hemostasis and Thrombosis, 3, 1–28.
- Huhtasaari, F., et al., 1999. Smokeless tobacco as a possible risk factor for myocardial infarction: a population-based study in middle-aged men. Journal of the American College of Cardiology, 34, 784–790.
- Joseph, A.M., et al., 1996. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. The New England Journal of Medicine, 335 (24), 1792–1798.
- Jung, B., et al., 1999. Simultaneous GC–MS determination of nicotine and cotinine in plasma for the pharmacokinetic characterization of nicotine in rats. Journal of Pharmaceutical and Biomedical Analysis, 20 (1–2), 195–202.
- Lakier, J.B., 1992. Smoking and cardiovascular disease. The American Journal of Medicine, 93, 8–12.
- Lambeth, J.D., 2004. NOX enzymes and the biology of reactive oxygen. Nature Reviews. Immunology, 4 (3), 181–189.
- Li, J.M., et al., 2002. Essential role of the NADPH oxidase subunit p47(phox) in endothelial cell superoxide production in response to phorbol ester and tumor necrosis factor-alpha. Circulation Research, 90 (2), 143–150.
- Li, Z., et al., 1994. Chronic nicotine administration does not affect peripheral vascular reactivity in the rat. The Journal of Pharmacology and Experimental Therapeutics, 271 (3), 1135–1142.
- Liu, C., et al., 2017. Oral nicotine aggravates endothelial dysfunction and vascular inflammation in diet-induced obese rats: Role of macrophage TNFα. PLoS One, 12 (12), e0188439.
- Lowenstein, C.J., Dinerman, J.L., and Snyder, S.H., 1994. Nitric oxide: a physiologic messenger. Annals of Internal Medicine, 120 (3), 227–237.
- Mayhan, W.G. and Patel, K.P., 1997. Effect of nicotine on endothelium-dependent arteriolar dilatation in vivo. The American Journal of Physiology, 272 (5 Pt 2), H2337–H2342.
- Michel, T. and Feron, O., 1997. Nitric oxide synthases: which, where, how, and why? The Journal of Clinical Investigation, 100 (9), 2146–2152.
- Mizrak, S., et al., 2015. The effect of long term pre/postnatal low/high dose nicotine exposure on tissue oxidant/antioxidant status and DNA damage in rats. Drug Research, 65, 432–436.
- Palmer, R.M., Ferrige, A.G., and Moncada, S., 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature, 327 (6122), 524–526.
- Rajendran, P., et al., 2013. The vascular endothelium and human diseases. International Journal of Biological Sciences, 9 (10), 1057–1069.
- Sastry, B.V.R., et al., 1998. Formation and retention of cotinine during placental transfer of nicotine in human placental cotyledon. Pharmacology, 57 (2), 104–116.
- Sengupta, P., 2013. The laboratory rat: relating its age with human’s. International Journal of Preventive Medicine, 4 (6), 624–630.
- Steyers, C.M., 3rd and Miller, F.J., Jr. 2014. Endothelial dysfunction in chronic inflammatory diseases. International Journal of Molecular Sciences, 15 (7), 11324–11349.
- Vane, J.R., Anggård, E.E., and Botting, R.M., 1990. Regulatory functions of the vascular endothelium. The New England Journal of Medicine, 323 (1), 27–36.
- Wang, X., et al., 2004. Effects of nicotine on the number and activity of circulating endothelial progenitor cells. Journal of Clinical Pharmacology, 44 (8), 881–889.
- Zevin, S., Jacob, P., 3rd, and Benowitz, N.L., 1998. Dose-related cardiovascular and endocrine effects of transdermal nicotine. Clinical Pharmacology & Therapeutics, 64 (1), 87–95.